News & Events
-
May 9, 2017
Two Arizona leaders in scientific collaboration partner to advance global TB research
May 1, 2017 Two Arizona leaders in scientific collaboration partner to advance global TB research TUCSON and FLAGSTAFF, May 1, 2017 –Two Arizona leaders in worldwide scientific collaboration and infectious disease research have joined forces to improve global tuberculosis (TB) treatment regimens by studying drug resistance. The Bill & Melinda Gates Foundation has... -
May 9, 2017 - May 10, 2017
Advancing CDISC Standards for Biosensors Assessments in Clinical Drug Trials: 2017 Biometric Monitoring Device Workshop
May 9-10, 2017 Bethesda North Marriott Hotel and Conference Center Bethesda, MD Meeting Overview/Objectives: Review contemporary use cases for mobile biosensor assessments of three domains of function that are impacted by Neurological Disorders (mobility/sleep/cognitive performance). Review & address key regulatory considerations for various Contexts-of-Use. Convene CDISC Standard experts to advance a plan that enables data... -
May 1, 2017
Critical Path Institute and TGen Forge Partnership to Advance TB Research
May 1, 2017 Critical Path Institute and TGen Forge Partnership to Advance TB Research TUCSON and FLAGSTAFF, May 1, 2017 – The Critical Path to TB Drug Regimens (CPTR), an initiative of the Critical Path Institute (C-Path), has received a $1.1 million grant from the Bill & Melinda Gates Foundation to significantly enrich its... -
May 1, 2017
Tuberculosis and Antimicrobial Resistance – New Models of Research and Development Needed
Brigden G, Castro JL, Ditiu L, Gray G, Hanna D, Low M, Matsoso MP, Perry G, Spigelman M, Swaminathan S, Torreele E, Wong S. Tuberculosis and Antimicrobial Resistance – New Models of Research and Development Needed. Bulletin of the World Health Organization. 2017 May 1;95(5):315.
-
April 26, 2017
Critical Path Institute Launches Transplant Therapeutics Consortium
April 26, 2017 Critical Path Institute Launches Transplant Therapeutics Consortium Tucson, Ariz., April 26, 2017 –Critical Path Institute (C-Path) is pleased to announce the launch of the Transplant Therapeutics Consortium (TTC), co-founded by the two leading US organizations in organ transplantation: the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS)....